Labels

Showing posts with label Medical Device. Show all posts
Showing posts with label Medical Device. Show all posts

Friday 2 August 2019

Biosensor Market increasing moderately Globally


Biosensors Market Overview:
Biosensors are analytical devices composed of biological detecting elements like sensor system and a transducer for providing analytical information. To recognize the function and structure of different molecules, these devices help convert the biological response into an electrical response. When compared with any other existing diagnostic devices, the biosensors are much more advanced in terms of selectivity and sensitivity. Its effective capability of prompt detection and measuring wide spectrum across different applications make it a highly beneficial device. Its applications stretch into the field of healthcare, environmental monitoring, industrial process control, military application, agriculture, and veterinary monitoring. In the agricultural and food industries, its use involves the checking of ecological pollution control. According to the in-depth research conducted by Market Research Future (MRFR), the global biosensor market is expected to grow at a moderate pace due to a number of factors. Factors like the increasing demand of Point-of-Care Testing (POCT), wide-spread prevalence of the diabetes and chronic and lifestyle-based diseases, rise in the geriatric population, and expanding applications of biosensors in various sectors are all contributing to the overall growth of the market. The market is forecasted to grow at a rate of 9.6% during the review period between 2014 to 2020.


Market Segmentation
The global biosensor market segmentation is done on the basis of technology, application, and end-user.
By technology, the market divides into thermal biosensors, electrochemical biosensors, piezoelectric biosensors, optical biosensors, and others. The piezoelectric biosensors hold the largest share in this market segment.
By application, the market includes industrial process, agricultural testing, medical testing, environmental market, into food toxicity, and others.
By end-user, the market comprises research laboratories, security and biodefense, food industry, point of care, home diagnostics, and others. The security and biodefence segment is the biggest market share holder because of the increasing biological threats and the proliferating need to protect them.

Regional Analysis
The biosensor market is geographically segmented into the Americas, Asia-Pacific, Europe, and the Middle East & Africa.
The Americas region is the largest market for biosensors in the world. Out of the two American continents, North America accounts for the largest market share. The North American region is further narrowed down into the US, which is most prominent regional country in the region. The region is increasingly willing to adopt new and advancing healthcare technologies and boasts high technological capability. Also, the presence of various leading market players and a surging diabetic population is also expected to accelerate the demand for the biosensor market.
The European regional market is also growing at a continuous pace and is gradually catching up to the North American market. The presence of a huge geriatric population therein is driving the regional market in Europe.
The Asia-Pacific regional market is expected to grow with the highest CAGR due to the potential the region holds. The region holds a high percentage of emerging markets and there lies an increasing focus on the provision of high-quality healthcare. The APAC market is expected to grow at an exponential pace due to the overall increase in demand for biosensor technology.

Competitive Landscape
The global biosensor market holds a number of key players including Nova Biomedical Corporation, F. Hoffmann-La Roche Ltd., TiaDoc Technology Corporation, LifeSensors Inc., Medtronic, Inc., Siemens Healthcare, Abbott Laboratories Inc., I-SENCE Inc., Johnson & Johnson, and Bayer Healthcare.

Table Of Content
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Biosensors Market By Type
7 Global Biosensors Market by Technology
...

Related Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , , ,

Monday 24 June 2019

Biosensor Market Is Booming Worldwide | Global Key Players and Industry Insight

Biosensors Market  Overview:
Biosensors are analytical devices composed of biological detecting elements like sensor system and a transducer for providing analytical information. To recognize the function and structure of different molecules, these devices help convert the biological response into an electrical response. When compared with any other existing diagnostic devices, the biosensors are much more advanced in terms of selectivity and sensitivity. Its effective capability of prompt detection and measuring wide spectrum across different applications make it a highly beneficial device. Its applications stretch into the field of healthcare, environmental monitoring, industrial process control, military application, agriculture, and veterinary monitoring. In the agricultural and food industries, its use involves the checking of ecological pollution control. According to the in-depth research conducted by Market Research Future (MRFR), the global biosensor market is expected to grow at a moderate pace due to a number of factors. Factors like the increasing demand of Point-of-Care Testing (POCT), wide-spread prevalence of the diabetes and chronic and lifestyle-based diseases, rise in the geriatric population, and expanding applications of biosensors in various sectors are all contributing to the overall growth of the market. The market is forecasted to grow at a rate of 9.6% during the review period between 2014 to 2020.
Biosensors Market Competitive Landscape
The global biosensor market holds a number of key players including
  • Nova Biomedical Corporation
  • F. Hoffmann-La Roche Ltd.
  • TiaDoc Technology Corporation
  • LifeSensors
  • Medtronic
  • Siemens Healthcare
  • Abbott Laboratories
  • I-SENCE 
  • Johnson & Johnson,
  • Bayer Healthcare.
Biosensors Market Regional Analysis
The biosensor market is geographically segmented into the Americas, Asia-Pacific, Europe, and the Middle East & Africa.
The Americas region is the largest market for biosensors in the world. Out of the two American continents, North America accounts for the largest market share. The North American region is further narrowed down into the US, which is most prominent regional country in the region. The region is increasingly willing to adopt new and advancing healthcare technologies and boasts high technological capability. Also, the presence of various leading market players and a surging diabetic population is also expected to accelerate the demand for the biosensor market.
The European regional market is also growing at a continuous pace and is gradually catching up to the North American market. The presence of a huge geriatric population therein is driving the regional market in Europe.
The Asia-Pacific regional market is expected to grow with the highest CAGR due to the potential the region holds. The region holds a high percentage of emerging markets and there lies an increasing focus on the provision of high-quality healthcare. The APAC market is expected to grow at an exponential pace due to the overall increase in demand for biosensor technology.
Biosensors Market Segmentation
The global biosensor market segmentation is done on the basis of technology, application, and end-user.
By technology, the market divides into thermal biosensors, electrochemical biosensors, piezoelectric biosensors, optical biosensors, and others. The piezoelectric biosensors hold the largest share in this market segment.
By application, the market includes industrial process, agricultural testing, medical testing, environmental market, into food toxicity, and others.

By end-user, the market comprises research laboratories, security and biodefense, food industry, point of care, home diagnostics, and others. The security and biodefence segment is the biggest market share holder because of the increasing biological threats and the proliferating need to protect them.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Thursday 2 May 2019

Increasing Technological Advancement In Hemostats Market – Global Industry Forecast to 2023

Market Highlights
Hemostasis is the course of blood clotting. Blood clotting plays a vital role in various surgeries by achieving positive outcomes with the reduction of blood loss. This clotting process reduces the surgery time and the need for blood transfusion. Thus, hemostats are surgical instruments used to regulate the bleeding during surgery. Hemostats are also used for oozing out venomous bleeds, bone bleeding, and others. The scope of hemostats is growing rapidly with technological advancements and a growing number of surgeries. Also, growth in a number of hospitals and healthcare facilities, and initiatives taken by the government are the major factors driving the growth of the hemostats market.
The hemostats market is expected to grow at a CAGR of 6.4%.
However, the high cost of hemostats, government’s rules and regulations and lack of skilled professionals is expected to hamper the growth of hemostats market.
Segmentation
The global hemostats market has been segmented on the basis of product type, instrument type, application, and end-user.
On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants.  On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps. On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others.
Regional Analysis
The Americas is projected to lead the hemostats market in the forecast period. Rising rate in a number of diseases due to various factors such as a change in lifestyle, rising geriatric population and others contribute majorly to the growth of the market. Increasing healthcare awareness, advancement in technology, medical tourism, and an increase in disposable income are some other factors that boost the growth of the market.  According to the United States Center for Disease Control and Prevention, around 45% of the American population is suffering from at least one chronic condition demanding critical care.
The European market is expected to hold the second largest market share. Introduction of technologically advanced hemostat products such as FLOSEAL, HEMOPATCH, and TISEEL is projected to boost the demand for these products in the European market. The European hemostats market is anticipated to be driven due to the increase in the elderly aged population, which is expected to ultimately lead to a higher number of surgeries. The European market is projected to grow because of the increase in elderly population, growing prevalence of diabetes, and heart rhythm problems in the region.
Asia-Pacific was projected to be the fastest growing region for the global hemostats market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Key Players
Some of the key players in the global hemostats market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation (US).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , , , , , , ,

Sunday 14 April 2019

Human Vaccines Market Top Players Share, Trend, Technology, Growth and Forecast to 2022

Market Overview:
Rapid advancement in technology is aiding the healthcare sector for development of innovative diagnostics and treatment solutions. Human vaccines are biological preparations that aid in improving immunity towards particular disease. Market Research Future (MRFR) has published a report stating that the Middle East and Africa Human Vaccines Market is marked to expand at a noteworthy CAGR of 11.8% during the forecast period of 2016-2022 and reach the valuation of USD 5.46 Bn by the end of the assessment period.
Market Drivers and Restraints:
Lack of awareness regarding the causative agents of diseases and low importance to sanitation and hygiene in the underdeveloped areas of Middle East and Africa region have led to the outbreak of various epidemics, causing major health concerns among the population of this region. Various diseases are being spread from these underdeveloped regions various parts of the world through the means of diseases carrying vectors. Multiple governmental and non-governmental organizations are taking the initiative of mass immunization in this region, which is majorly propelling the growth of the Middle East and Africa human vaccines market. 
Increasing investment for research and development for developing vaccines that are highly effective on endemic diseases such as Lassa fever, Ebola and others are fueling the expansion of the Middle East and Africa human vaccines market. Rise in disposable income and increased healthcare expenditure by the population of developed areas of this region are some other factors that are resulting in the significant expansion of the Middle East and Africa human vaccines market. However, lack of awareness and religious constraints towards vaccines are likely to act as a restraint on the expansion of the Middle East and Africa human vaccines market during the forecast period.
Market Segmentation:
The Middle East and Africa human vaccines market has been segmented on the basis of technology, disease indication, type, composition, route of administration and end user. Based on technology, the human vaccines market has been segmented into attenuated, inactivated, toxoid, conjugate and subunit and recombinant DNA. Based on disease indication, the human vaccines market has been segmented into pneumococcal, influenza, hepatitis, rotovirus, DTP, polio and others. Based on type, the human vaccine market has been segmented into prophylactic and therapeutic. Based on composition, the human vaccines market has been segmented into mono vaccine and combination vaccines. Based on route of administration, the human vaccines market has been segmented into oral, injectable and others. Based on end user, the human vaccines market has been segmented into children and adults.
Regional Analysis:
Geographically, the Middle East and Africa human vaccines market has been segmented into major countries such as UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. The UAE region commands for the major share in the Middle East and Africa human vaccine market owing to the rapid development of healthcare sector, increased investments for adoption of technologically advanced healthcare solutions and high healthcare expenditure in this region. The UAE region is closely followed by Egypt in case of market size. Huge unmet medical needs and increasing government initiatives for facilitating proper healthcare solutions in the underdeveloped countries of the African region are leading to the growth of the human vaccines market at the fastest rate in the Middle East and Africa human vaccines market.
Key Players:
The major players profiled by MRFR that are operating in the Middle East and Africa human vaccines market are GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Shenzhen Kangtai Biological Products,  Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech, Emergent Biosolutions Inc., Astellas Pharma Inc., Panacea Biotec Valeant Pharmaceuticals,  and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Sunday 31 March 2019

New Master Plan Boost Medical Tourism Market Growth From USD 70,836.9 million to a staggering USD 226,762.7 million

Market Insights
Increasing costs of treatments for chronic diseases and other kinds of treatment have been highly encouraging of medical tourism. It has been a common practice in an effort to procure good treatment at lower costs. Developing economies around the world offer high-quality medical treatments which attract patients from other parts of the world. Market Research Future has published its newest report on the global medical tourism market which reveals an expected and promising CAGR of  21.4% during the forecast period from 2017 to 2023. The market was found to be valued at USD 70,836.9 Mn at the start of the forecast period and is likely to grow to reach an impressive USD 226,762.7 Mn by the end of 2023.

Download Free Sample Report Here !! https://www.marketresearchfuture.com/sample_request/1975

In the US, an angioplasty treatment would cost well over USD 55,000. However, in India, the cost is a fraction of the price as USD 3,300. The drastic difference in costs has led patients in developed countries with high healthcare costs to seek treatment in countries which are emerging rapidly and have a similar medical infrastructure. The reduces waiting time for treatment in these countries is also a significant factor driving growth for the global market. Timely treatment is the key to speedy recovery. However, the prevalence of chronic diseases in some developed countries has resulted in waiting lists for treatments. These waiting lists can easily be skipped via medical tourism. Developing countries are positioning themselves as medical tourism hubs with plenty of support from local governments, thus increasing market growth. Investments in healthcare sectors of these countries have ensured high-quality treatments at comparatively low prices. Language barriers and long travel times are expected to work against market growth and challenge the global medical tourism market.
Market Segmentation
The global medical tourism market is segmented on the basis of type. This is divided into neurology/neurosurgery treatments, orthopedic/spine treatments, fertility/IVF treatments, cosmetic treatments, cardiovascular/cardiology treatments, oncology/cancer treatments, and dental treatments. Among these, The cosmetic treatments market is the most lucrative segment with a high demand for facial rejuvenation and breast reconstruction treatments. The cost-efficient prices at medical tourism destinations for cosmetic procedures drive the segment's growth.
Regional Analysis
The Asia Pacific, due to a high concentration of developing economies has a 43.7% share of the market making it the market leader by regional assessment. Investments in technological advancements and state of the art medical machinery are augmenting market growth. Moreover, The region includes South Korea which is a highly popular destination for cosmetic procedures. The APAC is expected to grow at a highly promising CAGR of 22% during the forecast period. Eastern and Central Europe also represent an important regional segment which is growing rapidly and is expected to establish itself as a medical tourism destination over the forecast period.
Key Players
Noted market players that are included in the report are Asklepios Kliniken Verwaltungsgesellschaft mbH, Shouldice Hospital, Bangkok Hospital, Bumrungrad International Hospital, Samitivej PCL, CHRISTUS MUGUERZA, Clemenceau Medical Center, Anadolu Medical Center, Prince Court Medical Centre, Fortis Healthcare, Gleneagles Global Hospitals Group, and Schoen-Kliniken. These market players are extensively profiled in MRFR's competitive analysis.
Latest Industry News
  • Abu Dhabi's Department of Culture and Tourism has just signed an MOU with the Medical Tourism Association to partner in its efforts to establish itself as a high-quality medical tourism destination
  • Cancun, Mexico, has begun development of "Health City" with the help of third-party The location of the project is situated 10 minutes from the airport and aims to increase medical tourism activities.

Posted by at No comments:
Labels: , , , , ,

Monday 18 March 2019

Medical Device Market Research Report

Medical Device Market Research Report
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)